|
335 Second
counterfeit medicine discovered in UK Pharmacists who discover
they have unwittingly dispensed counterfeit Reductil should contact patients
to alert them to check their medicines, according to official advice
from the Royal Pharmaceutical Society ...more
335 MHRA
repeats warning on unsafe TCMs A warning that there can be
no guarantee of the safety or quality of traditional Chinese medicines
(TCMs) has been reissued by the Medicines and Healthcare products Regulatory
Agency ...more
335 Imports
fracture confidence, claims Patients Association Patients are beginning to lose confidence in the integrity and safety of medicines dispensed by community pharmacies because of parallel importing, according to the Patients’ Association (PA)
...more
335 The
Independent to publish pharmacy careers supplement For
the second time this year, a special supplement promoting careers in
pharmacy is to be circulated with The Independent ...more
336 Hospital chief pharmacists set to earn over £80,000 Hospital chief pharmacists whose jobs fall into band 9 of the new pay arrangements under Agenda for change will receive salaries of between £66,063 and £83,546
...more
336 Discrimination
act deadline approaches Community pharmacists must make their
premises accessible to disabled customers or face potentially expensive
legal claims, the Pharmacy Mutual Insurance company has warned ...more
336 MPs investigate pharmaceutical industry’s influence on DoH Members
of Parliament began hearings this week to investigate the influence the
pharmaceutical industry is able to exert over the Department of Health
...more
336 Public
health minister visits community pharmacy in Leeds
...more
336 Welsh
prescription charges On 1 October prescription charges in Wales will be reduced from £6 to £5, in the first step towards abolishing all prescription charges by 2007, as pledged by the Welsh Assembly Government
...more
336 Mental
health bill published Major reform of mental health legislation
looks certain following the publication of the revised draft mental health
bill on 8 September ...more
336 Pharmacy
staff organisation A new professional association has been
formed for pharmacy staff ...more
336 Breast cancer
study The Breakthrough Generations study, which will investigate
the genetic, environmental, behavioural and hormonal factors influencing
risk of breast cancer, is seeking to recruit more than 100,000 UK women
...more
336 SMC on risperidone Risperidone
has been accepted for use within NHS Scotland by the Scottish Medicines
Consortium for the treatment of episodes of mania in bipolar disorder
...more
337 Patients
with COPD are missing out on treatment Patients with chronic
obstructive pulmonary disease (COPD) may be missing out on appropriate
treatment, according to a primary care study presented at the European
Respiratory Society meeting in Glasgow this week ...more
337 Superdrug
pharmacists to offer spirometry to target COPD Pharmacists
at 20 Superdrug stores across the UK will be offering spirometry tests
to about 1,000 smokers in the week of 15 November, as part of British
Lung Foundation activities to mark World COPD Day ...more
337 Old sulphonylureas
have higher MI risk than newer agents Treatment with “older” sulphonylureas is associated with twice the risk of a myocardial infarction than “newer” agents in this class (such as glimepiride and gliclazide), according to data presented at the European Association for the Study of Diabetes meeting
...more
337 Rosuvastatin
improves lipid profile in metabolic syndrome Low-dose rosuvastatin
achieves major reductions in LDL-cholesterol and increases HDL-cholesterol
in patients with metabolic syndrome, according to results from an AstraZeneca-sponsored
study reported at the European Association for the Study of Diabetes
meeting in Munich ...more
337 Treatment
hope for urinary incontinence with multiple sclerosis or spinal cord
injury Two new treatments — cannabinoids and botulinum toxin — have been shown to have some clinical benefit in treating urinary incontinence related to multiple sclerosis or spinal cord injury
...more
|
338 BP targets
unachievable in most patients Current blood pressure targets
are unachievable in most patients, primary care specialists say. They
suggest that it is more important to find out what patients want from
treatment than to strive to achieve the targets ...more
338 Strong evidence
to treat systolic hypertension in the over-60s There is strong
evidence of the benefits of treating systolic hypertension in patients
aged 60 years and over, according to a review which identified over 1,000
studies and selected 36 for inclusion ...more
338 Benefit of
beta blockers in elderly heart failure patients A trial has,
for the first time, confirmed the benefit of beta-blockers in elderly
patients with heart failure ...more
338 Can vessel
endothelium predict cardiovascular risk in children? Changes
in children’s small blood vessel function may predict future heart
disease. So said Dr Faisal Khan, of Dundee university, speaking at this
week’s British Association science festival in Exeter ...more
339 New guide
to NHS modernisation launched A definitive guide to modernising
the NHS was launched this week by the NHS Modernisation Agency ...more
339 Medicines
management guide launched for PCTs and NHS trusts How the
medicines management aspects of national service frameworks should be
implemented is set out in a new resource published this week by the Department
of Health ...more
339 £6m
cancer project Nine areas of England are to pilot schemes
to improve the quality of care for cancer patients. The two-year pilots
will cost £6m ...more
339 FIP launches
pharmacists’ HIV/AIDS network The International Pharmaceutical
Federation (FIP) has launched an online HIV/AIDS network for pharmacists
...more
339 Patient information
on the internet is too complicated Websites giving information
for diabetes patients are too complicated for most people ...more
R&D news
340 Osteoarthritis
patients may benefit from new drug Lumiracoxib, a cyclo-oxygenase
2-selective inhibitor due to be launched in the UK next year, has been
shown to cause fewer ulcer complications in patients with osteoarthritis
than naproxen or ibuprofen, without increasing the rate of serious cardiovascular
events ...more
340 Gene
therapy slows prostate cancer growth The development and progression
of prostate cancer could be slowed by a new gene therapy technique ...more
340 Leptin
injection may be useful in amenorrhoea Injection of recombinant
human leptin has successfully treated hypothalamic amenorrhoea in a recent,
small US study ...more
340 Genetic
markers may predict response to DMARDs aa
...more
340 Liraglutide
trial results positive New data have shown that liraglutide,
a long-acting analogue of GLP-1 hormone currently under investigation
by Novo Nordisk for type 2 diabetes, can provide improved blood glucose
control without associated weight gain ...more
|
The
Pharmaceutical Journal